I 

118TH CONGRESS 

2D SESSION H. R. 10497 

To amend title 18, United States Code, to provide for certain rules for 

housing or transportation based on gender and to provide for a limitation 

on gender-related medical treatment. 

IN THE HOUSE OF REPRESENTATIVES 

DECEMBER 18, 2024 

Ms. MACE introduced the following bill; which was referred to the Committee 

on the Judiciary 

A BILL 

To amend title 18, United States Code, to provide for certain 

rules for housing or transportation based on gender and 

to provide for a limitation on gender-related medical 

treatment. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Prison Rape Preven5 tion Act of 2024’’. 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 10497 IH

1 SEC. 2. RULES FOR HOUSING OR TRANSPORTATION BASED 

2 ON GENDER; LIMITATION ON GENDER-AF3 FIRMING CARE. 

4 Section 3621 of title 18, United States Code, is 

5 amended by adding at the end the following: 

6 ‘‘(j) RULES FOR HOUSING OR TRANSPORTATION

7 BASED ON GENDER; LIMITATION ON GENDER-AFFIRMING

8 CARE.—Notwithstanding any other provision of law, the 

9 Bureau of Prisons— 

10 ‘‘(1) shall ensure that a prisoner is placed, dur11 ing that prisoner’s term of imprisonment, only 

12 among prisoners of the same biological sex as the 

13 prisoner; 

14 ‘‘(2) shall ensure that a prisoner, when trans15 ported in the company of other prisoners, is only 

16 transported among prisoners of the same biological 

17 sex as the prisoner; and 

18 ‘‘(3) may not furnish or pay for any gender-re19 lated medical treatment. 

20 ‘‘(k) DEFINITIONS.—For purposes of subsection (j): 

21 ‘‘(1) BIOLOGICAL SEX.—The term ‘biological 

22 sex’ means the biological determination as to wheth23 er an individual is male or female. 

24 ‘‘(2) FEMALE.—The term ‘female’ means an in25 dividual who naturally has, had, will have, or would 

26 have, but for a developmental or genetic anomaly or 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 10497 IH

1 historical accident, the reproductive system that at 

2 some point produces, transports, and utilizes eggs 

3 for fertilization. 

4 ‘‘(3) MALE.—The term ‘male’ means an indi5 vidual who naturally has, had, will have, or would 

6 have, but for a developmental or genetic anomaly or 

7 historical accident, the reproductive system that at 

8 some point produces, transports, and utilizes sperm 

9 for fertilization. 

10 ‘‘(4) GENDER.—The term ‘gender’— 

11 ‘‘(A) means— 

12 ‘‘(i) males, females, or the natural dif13 ferences between males and females, unless 

14 such term is otherwise specified or used 

15 alone (rather than with or as an adjective 

16 modifying other words); and 

17 ‘‘(ii) a synonym for sex; and 

18 ‘‘(B) does not mean a synonym for terms 

19 or ideas such as gender identity, experienced 

20 gender, gender expression, or gender roles 

21 ‘‘(5) GENDER-RELATED MEDICAL TREAT22 MENT.—The term ‘gender-related medical treat23 ment’— 

24 ‘‘(A) means— 


ssavage on LAPJG3WLY3PROD with BILLS
4 

•HR 10497 IH

1 ‘‘(i) with respect to a female indi2 vidual, medical treatments provided for 

3 purposes of addressing the perception of 

4 such individual that the gender or sex of 

5 such individual is not female, including— 

6 ‘‘(I) surgical procedures, includ7 ing— 

8 ‘‘(aa) vaginectomy; 

9 ‘‘(bb) hysterectomy; 

10 ‘‘(cc) oophorectomy; 

11 ‘‘(dd) reconstruction of the 

12 urethra; 

13 ‘‘(ee) metoidioplasty; 

14 ‘‘(ff) phalloplasty; 

15 ‘‘(gg) salpingo16 oophorectomy; 

17 ‘‘(hh) scrotoplasty; 

18 ‘‘(ii) implantation of erection 

19 or testicular protheses; 

20 ‘‘(jj) subcutaneous mastec21 tomy; 

22 ‘‘(kk) vocal cord surgery; 

23 ‘‘(ll) pectoral implants; and 

24 ‘‘(mm) penile transplan25 tation; 


ssavage on LAPJG3WLY3PROD with BILLS
5 

•HR 10497 IH

1 ‘‘(II) exogenous doses of testos2 terone or other androgens; 

3 ‘‘(III) puberty blockers, includ4 ing— 

5 ‘‘(aa) GnRH agonists; and 

6 ‘‘(bb) synthetic drugs that 

7 suppress the production of estro8 gen and progesterone or delay or 

9 suppress pubertal development in 

10 female individuals; and 

11 ‘‘(IV) such other medical treat12 ment, identified by the Director of the 

13 Federal Bureau of Prisons, that may 

14 be provided for purposes of addressing 

15 the perception of such individual that 

16 the gender or sex of such individual is 

17 not female; and 

18 ‘‘(ii) with respect to a male individual, 

19 medical treatments provided for purposes 

20 of addressing the perception of such indi21 vidual that the gender or sex of such indi22 vidual is not male, including— 

23 ‘‘(I) surgical procedures, includ24 ing— 

25 ‘‘(aa) penectomy; 


ssavage on LAPJG3WLY3PROD with BILLS
6 

•HR 10497 IH

1 ‘‘(bb) orchiectomy; 

2 ‘‘(cc) vaginoplasty; 

3 ‘‘(dd) clitoroplasty; 

4 ‘‘(ee) vulvoplasty; 

5 ‘‘(ff) augmentation 

6 mammoplasty; 

7 ‘‘(gg) facial feminization 

8 surgery; 

9 ‘‘(hh) vocal cord surgery; 

10 ‘‘(ii) chondrolaryngoplasty; 

11 ‘‘(jj) gluteal augmentation; 

12 and 

13 ‘‘(kk) uterine transplan14 tation; 

15 ‘‘(II) exogenous doses of estro16 gen; 

17 ‘‘(III) puberty blockers, includ18 ing— 

19 ‘‘(aa) GnRH agonists; and 

20 ‘‘(bb) synthetic drugs that 

21 suppress the production of testos22 terone or delay or suppress pu23 bertal development in male indi24 viduals; and 


ssavage on LAPJG3WLY3PROD with BILLS
7 

•HR 10497 IH

1 ‘‘(IV) such other medical treat2 ment, identified by the Director of the 

3 Federal Bureau of Prisons, that may 

4 be provided for purposes of addressing 

5 the perception of such individual that 

6 the gender or sex of such individual is 

7 not male; and 

8 ‘‘(B) does not include any medical 

9 treament performed on an individual for the 

10 purposes of treating— 

11 ‘‘(i) a disorder of sex development, di12 agnosed by a physician after such physi13 cian has determined through genetic or 

14 biochemical testing that such individual 

15 does not have normal sex chromosome 

16 structure, sex steroid hormone production, 

17 or sex steroid hormone action; 

18 ‘‘(ii) irresolvably ambiguous biological 

19 sex characteristics of such individual, in20 cluding the presence of— 

21 ‘‘(I) 46 XX chromosomes with 

22 virilization; 

23 ‘‘(II) 46 XY chromosomes with 

24 undervirilization; or 


ssavage on LAPJG3WLY3PROD with BILLS
8 

•HR 10497 IH

1 ‘‘(III) both ovarian and testicular 

2 tissue; or 

3 ‘‘(iii) an infection, injury, disease, or 

4 disorder caused or exacerbated by gender5 related medical treatment that was fur6 nished to an individual.’’. 

Æ 


ssavage on LAPJG3WLY3PROD with BILLS